Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-02

Clinical Trial Update: A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response. [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effect of a single dose of ibuprofen or fluticasone propionate on inflammatory markers and allergen response after a nasal allergen …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Pfizer | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED